The present invention describes a pharmaceutical composition with increased bioavailability, which is suitable for preparing microcapsules for the therapeutic administration of a protease inhibitor. Packets from the buffers are combined for the plurality of users into a buffer for the pseudo user. A reversion pacing mode is provided in order to prevent tachyarrhythmia detection from being compromised when the rate ventricle is paced after the other ventricle. The pole comprises a first mounting bracket and a second mounting bracket. Additional bursts can also be written, such as for each data track centerline.